Can't get Xdemvy for your Demodex blepharitis? Explore proven alternatives including tea tree oil scrubs, Ivermectin, BlephEx, and IPL therapy.
Xdemvy (Lotilaner ophthalmic solution 0.25%) changed the game for Demodex blepharitis treatment when it became the first FDA-approved medication for the condition. But what if you can't get your hands on it? Whether your insurance denied coverage, the cost is too high, or the specialty pharmacy process is taking too long, you still have options.
Let's look at what Xdemvy does, how it works, and what alternatives you can discuss with your eye doctor.
Xdemvy is a prescription eye drop made by Tarsus Pharmaceuticals. It's the only FDA-approved treatment specifically targeting Demodex blepharitis — inflammation of the eyelids caused by Demodex mites. These tiny, microscopic mites naturally live on human skin, but when they overpopulate on the eyelids, they can cause:
Many people with these symptoms are initially told they have dry eye or allergic conjunctivitis, and they may go years without a proper Demodex diagnosis. For a deeper look at the condition and treatment, visit our guide on what Xdemvy is and how it's used.
Xdemvy's active ingredient, Lotilaner, belongs to the isoxazoline parasiticide class. It works by blocking GABA-gated chloride channels in Demodex mites — essentially disrupting their nervous system, which paralyzes and kills them. The standard treatment is one drop in each affected eye, twice daily, for six weeks. This six-week course is designed to cover at least two complete Demodex life cycles to ensure thorough eradication.
For more on the science, see our article on how Xdemvy works.
There are several reasons you might be looking for alternatives to Xdemvy:
Tea tree oil has been the traditional go-to treatment for Demodex blepharitis for years before Xdemvy was approved. The active component that kills Demodex mites is Terpinen-4-ol (T4O), which is found naturally in tea tree oil.
How it works: Tea tree oil has acaricidal (mite-killing) properties. When applied to the eyelid margins, it can reduce Demodex mite populations over time.
How to use it:
Pros: Available over the counter, no prescription needed, relatively affordable ($15-$30 per month)
Cons: Less effective than Xdemvy in clinical studies, can cause eye irritation if not properly diluted, requires strict daily compliance, and results may be slower and less complete
Ivermectin is an anti-parasitic medication that has been used off-label for Demodex blepharitis. It's available in both oral tablet form and as a topical cream.
How it works: Ivermectin disrupts nerve and muscle function in parasites, leading to their paralysis and death. While not FDA-approved for ocular Demodex, studies have shown it can reduce mite counts.
How to use it:
Pros: Much more affordable than Xdemvy (oral Ivermectin costs $10-$30), widely available at regular pharmacies, well-established safety profile
Cons: Not FDA-approved for this use, oral form has systemic side effects, topical cream is not formulated for direct eye use, may be less effective than Lotilaner for eyelid-specific mites
BlephEx is an in-office procedure performed by your eye care provider. It uses a specialized spinning micro-sponge to mechanically remove Demodex mites, biofilm, bacterial toxins, and debris from the eyelid margins.
How it works: The procedure physically exfoliates the eyelid margins, removing mites and the material they feed on. It takes about 6-8 minutes per session.
Pros: Immediate mechanical removal of mites and debris, performed by a professional, can provide quick symptom relief
Cons: Requires an office visit ($100-$200 per session, often not covered by insurance), may need to be repeated every 4-6 months, doesn't prevent mite repopulation on its own, often used as a complement to other treatments rather than a standalone solution
IPL therapy is a light-based treatment originally developed for skin conditions like rosacea. Eye care providers have found it can also help manage Demodex blepharitis and improve meibomian gland function.
How it works: IPL delivers pulses of light to the skin around the eyes, which helps reduce inflammation, kill Demodex mites, and improve oil gland function in the eyelids.
Pros: Can address both Demodex and meibomian gland dysfunction simultaneously, long-lasting results for some patients, non-invasive
Cons: Expensive ($300-$600 per session, typically 3-4 sessions needed), usually not covered by insurance, requires in-office visits, not suitable for all skin types, results vary
Xdemvy remains the gold standard for Demodex blepharitis because it's the only treatment that was rigorously tested in large clinical trials and received FDA approval specifically for this condition. In those trials, Xdemvy showed significant mite eradication and symptom improvement within the 6-week treatment course.
However, the alternatives listed above have been used by eye care providers for years and can be effective, especially when combined. Many doctors recommend a multi-pronged approach — for example, using tea tree oil scrubs for ongoing lid hygiene after completing a course of Xdemvy or another treatment.
If you can't fill your Xdemvy prescription right now, don't give up on treating your Demodex blepharitis. Talk to your eye doctor about which alternative makes the most sense for your situation. In many cases, a combination approach can provide meaningful relief while you work on getting access to Xdemvy.
And if cost or access is the issue, explore the savings options available — the Xdemvy Savings Card and Tarsus Connect Patient Assistance Program can significantly reduce what you pay. Use Medfinder to check availability and compare your options.
More Xdemvy resources:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
